<HashMap><database>biostudies-literature</database><scores/><additional><submitter>He P</submitter><funding>NHLBI NIH HHS</funding><pagination>7438</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9718760</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(1)</volume><pubmed_abstract>Complex carbohydrates (glycans) are major players in all organisms due to their structural, energy, and communication roles. This last essential role involves interacting and/or signaling through a plethora of glycan-binding proteins. The design and synthesis of glycans as potential drug candidates that selectively alter or perturb metabolic processes is challenging. Here we describe the first reported sulfur-linked polysaccharides with potentially altered conformational state(s) that are recalcitrant to digestion by heparanase, an enzyme important in human health and disease. An artificial sugar donor with a sulfhydryl functionality is synthesized and enzymatically incorporated into polysaccharide chains utilizing heparosan synthase. Used alone, this donor adds a single thio-sugar onto th</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Chemoenzymatic synthesis of sulfur-linked sugar polymers as heparanase inhibitors.</pubmed_title><pmcid>PMC9718760</pmcid><funding_grant_id>R01 HL144970</funding_grant_id><pubmed_authors>Zhang F</pubmed_authors><pubmed_authors>Linhardt RJ</pubmed_authors><pubmed_authors>Xia K</pubmed_authors><pubmed_authors>Pham T</pubmed_authors><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Almond A</pubmed_authors><pubmed_authors>Green DE</pubmed_authors><pubmed_authors>Baytas S</pubmed_authors><pubmed_authors>DeAngelis PL</pubmed_authors><pubmed_authors>He P</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Chemoenzymatic synthesis of sulfur-linked sugar polymers as heparanase inhibitors.</name><description>Complex carbohydrates (glycans) are major players in all organisms due to their structural, energy, and communication roles. This last essential role involves interacting and/or signaling through a plethora of glycan-binding proteins. The design and synthesis of glycans as potential drug candidates that selectively alter or perturb metabolic processes is challenging. Here we describe the first reported sulfur-linked polysaccharides with potentially altered conformational state(s) that are recalcitrant to digestion by heparanase, an enzyme important in human health and disease. An artificial sugar donor with a sulfhydryl functionality is synthesized and enzymatically incorporated into polysaccharide chains utilizing heparosan synthase. Used alone, this donor adds a single thio-sugar onto th</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-19T22:59:59.916Z</modification><creation>2025-04-19T22:59:59.916Z</creation></dates><accession>S-EPMC9718760</accession><cross_references><pubmed>36460670</pubmed><doi>10.1038/s41467-022-34788-3</doi></cross_references></HashMap>